{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:49:20Z","timestamp":1791287360041,"version":"4.1.0"},"reference-count":51,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2003,3,15]]},"abstract":"<jats:p> Purpose: To estimate the risk of secondary leukemia as a function of the dose of epipodophyllotoxins and anthracyclines. <\/jats:p><jats:p> Methods: We conducted a case-control study of the risk of secondary leukemia or myelodysplasia after a solid tumor in childhood within the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique, including 61 patients with leukemia matched with 196 controls. The characteristics of the first cancer, the patient\u2019s family history of cancer, and the treatment (type, cumulative dose of chemotherapy, schedule of etoposide administration, and radiation dose delivered to active bone marrow) were compared in the two groups. <\/jats:p><jats:p> Results: Only two factors were found to increase the risk of leukemia in multivariate analysis, namely, the type of the first tumor, with an excess risk in patients with Hodgkin\u2019s disease (relative risk 6.4; 95% confidence interval [CI], 1.6 to 24) or osteosarcoma (relative risk 5; 95% CI, 1.3 to 19), and exposure to epipodophyllotoxins and anthracyclines. The risk of leukemia increased regularly with the cumulative dose of etoposide. In summary, patients who received between 1.2 and 6 g\/m<jats:sup>2<\/jats:sup> of epipodophyllotoxins or more than 170 mg\/m<jats:sup>2<\/jats:sup> of anthracyclines had a seven-fold higher risk (95% CI, 2.6 to 19) compared with patients who received lower doses or none of these drugs. The risk of leukemia in patients who received more than 6 g\/m<jats:sup>2<\/jats:sup> of epipodophyllotoxins was multiplied by 197 (95% CI, 19 to 2,058). The risk of leukemia was not increased by exposure to alkylating agents or radiotherapy. <\/jats:p><jats:p> Conclusion: Both epipodophyllotoxins and anthracyclines increase the risk of secondary leukemia. The current challenge is to minimize the mutagenic effects of these drugs by diminishing cumulative doses without losing the therapeutic benefits. <\/jats:p>","DOI":"10.1200\/jco.2003.04.100","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T17:44:34Z","timestamp":1047577474000},"page":"1074-1081","source":"Crossref","is-referenced-by-count":187,"title":["Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique"],"prefix":"10.1200","volume":"21","author":[{"given":"Marie-C\u00e9cile","family":"Le Deley","sequence":"first","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akthar","family":"Shamsaldin","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Raquin","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Lacour","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Sommelet","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Chompret","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Cayuela","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Bayle","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bernheim","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"de Vathaire","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Vassal","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[{"name":"From the Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Department of Medicine, the Hematology Unit, and the Cytogenetics Laboratory, Institut Gustave-Roussy, Villejuif; the Pediatric Hematology Unit and the Hematology Laboratory, H\u00f4pital Saint-Louis, Paris; INSERM Unit 521, Villejuif; and the Registre Lorrain des Cancers de l\u2019Enfant, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910101)67:1+<303::AID-CNCR2820671316>3.0.CO;2-4"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3221"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550170036012"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(97)00098-2"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00201-3"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252402"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950230205"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.569"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010725"},{"key":"R10","unstructured":"Cutuli B, Janvier M, de la Rochefordi\u00e8re, et al: [Leukemia and pre-leukemic conditions occurring after treatment of breast cancer.] Leuc\u00e9mies et \u00e9tats pr\u00e9leuc\u00e9miques survenus apr\u00e8s traitement d\u2019un cancer du sein. Presse Med 29:135,2000\u2013138,"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2722"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2651"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400876"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.9.1444"},{"key":"R15","unstructured":"Pedersen-Bjergaard J, Philip P, Larsen SO, et al: Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7:1975,1993\u20131986,"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Philpott NJ, Bevan DH, Gordon-Smith EC: Secondary leukaemia after MMM combined modality therapy for breast carcinoma. Lancet 341:1289,1993,","DOI":"10.1016\/0140-6736(93)91199-V"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.7.1430"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1039"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.1988"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005173222004"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930615)71:12<3873::AID-CNCR2820711214>3.0.CO;2-1"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8140(96)01713-6"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(98)00110-8"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/45\/12\/306"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/78.3.459"},{"key":"R27","unstructured":"Breslow NE, Day NE: Statistical methods in cancer research: Volume I. The analysis of case-control studies. IARC Sci Publ 32:5,1980\u2013338,"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<860::AID-IJC32>3.0.CO;2-L"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6832.951"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1583"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<54::AID-AJH17>3.0.CO;2-3"},{"key":"R32","unstructured":"Kikuta T, Shimazaki C, Hirai H, et al: [Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide]. Rinsho Ketsueki 37:1276,1996\u20131282,"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5080"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.405"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200003000-00008"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1080\/088800100276460"},{"key":"R37","unstructured":"Preussmann R: Carcinogenicity of nitrosoureas in humans. IARC Sci Publ 78:223,1986\u2013229,"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220102"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.301.6760.1077"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1177\/030089169307900204"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.19.1450"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690718"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910390506"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.8.1046"},{"key":"R45","unstructured":"Donaldson SS, Hancock SL, Hoppe RT: The Janeway lecture. Hodgkin\u2019s disease\u2013Finding the balance between cure and late effects. Cancer J Sci Am 5:325,1999\u2013333,"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(88)90227-0"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.8.1304"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870215)59:4<701::AID-CNCR2820590407>3.0.CO;2-V"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950200116"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.654"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.3109\/08880019509029553"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199803)30:3<165::AID-MPO7>3.0.CO;2-F"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2003.04.100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:33:54Z","timestamp":1653510834000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2003.04.100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,15]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,3,15]]}},"alternative-id":["10.1200\/JCO.2003.04.100"],"URL":"https:\/\/doi.org\/10.1200\/jco.2003.04.100","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,15]]}}}